Can I get Wegovy for weight loss in the UK?

The myth: Wegovy is just a slimming pen you can order like a supplement

This is the most common misunderstanding our prescribers encounter. Wegovy is not a diet product you can pick up after filling in a quick form. It is a Prescription-Only Medicine regulated by the MHRA, which means a qualified clinician must assess your medical history, current medications, and weight-related health before any prescription is written. The law exists because semaglutide has real clinical effects, and real contraindications. People with a personal or family history of medullary thyroid carcinoma, certain pancreatic conditions, or who are pregnant, breastfeeding, or trying to conceive are not suitable candidates. Under-18s are not licensed to use it either.

There is also a counterfeit problem worth knowing about. The MHRA has seized large volumes of fake weight-loss pens sold through social media and unverified websites. Sellers offering Wegovy without requiring a prescription are a serious red flag. You can check any online pharmacy's legitimacy in under a minute by searching its name on the GPhC pharmacy register, if it is not listed, walk away.

The legal route requires a consultation, clinical sign-off, and a prescription from a GPhC-registered pharmacy. That is not a bureaucratic hurdle; it is the thing keeping you safe.

What the licensed eligibility criteria for Wegovy actually say

The Wegovy licence covers adults in two groups. First: a BMI of 30 or above. Second: a BMI between 27 and 29.9 alongside at least one weight-related condition. Qualifying conditions include type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, and cardiovascular disease, among others. If you are unsure whether your BMI meets the threshold, the NHS BMI calculator is a reliable starting point.

BMI alone never tells the whole story. A prescriber will also look at your medication list, any relevant conditions, and your goals. For people from certain ethnic backgrounds (South Asian, Chinese, Middle Eastern, Black African or African-Caribbean) the clinical threshold is 2.5 kg/m² lower, reflecting evidence that health risks appear at lower BMI values in those groups. Our full eligibility criteria page covers this in detail, and our guide on what BMI is needed for Wegovy explains how the number fits into the wider assessment.

NICE's appraisal of Wegovy (TA875) applies specifically to NHS prescribing, it sets a narrower bar, requiring treatment within a specialist weight management service for a maximum of two years. Private prescribing follows the licensed criteria, which are broader. That distinction matters when you are working out whether you can use Wegovy for weight loss via the NHS versus a private route.

NHS access versus getting Wegovy privately

On the NHS, Wegovy is available through specialist weight management services under NICE guidance TA875. Waiting lists are commonly long, and the eligibility bar (including referral to a qualifying service) means many people who are technically eligible face a significant wait before treatment starts. Scotland, Wales, and Northern Ireland have different commissioning arrangements, so access varies by where you live.

For people who do not meet the NHS criteria, or who do not want to wait, a regulated private pharmacy is the alternative. At nume, every consultation is reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician who reads your answers and makes a clinical decision, not software running an algorithm. If you are approved, treatment is dispatched the same day for free next-working-day delivery by DPD. If the question is not just can you take Wegovy but how you actually get it started, our step-by-step guide to getting Wegovy walks through the full process.

Cost is a reasonable concern. Private Wegovy pricing varies by dose and provider; our Wegovy cost guide sets out what the market looks like and what a legitimate price should include. One transparent price covering consultation, prescription, treatment, and delivery is a better benchmark than the cheapest listing you can find.

Starting Wegovy: what the early weeks look like

If a prescriber confirms you are suitable and treatment begins, Wegovy is a once-weekly injection. The standard titration starts at 0.25mg to help your body adjust, then moves through 0.5mg, 1.0mg, and 1.7mg before reaching the 2.4mg maintenance dose, with approximately four weeks at each level. A higher 7.2mg dose option was approved by the MHRA in 2026 for eligible patients. Your prescriber sets the pace; you do not self-select your dose or skip rungs based on how you feel.

The most common side effects are gastrointestinal: nausea, loose stools, or constipation, particularly after a dose increase, usually settling within a week or two. Severe or persistent stomach pain that spreads to the back needs prompt medical attention. Our Wegovy overview covers the side-effect profile in full, and if you ever want to know about timing flexibility, our page on varying the injection schedule addresses that specifically.

Treatment works best alongside changes to diet and activity levels, the licence itself requires that. Semaglutide reduces appetite; it does not remove the need for a plan. If you are ready to see whether you are eligible, check your eligibility with our prescribers and get a clinical answer the same day.